Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Cronos Group

SNDL Inc.

After struggling in recent months, companies that focus on the booming marijuana sector could be primed for a takeoff.

Cannabis stocks could be primed for a breakout thanks to Reddit and Amazon

Tilray, Inc. (TLRY) Irwin Simon Presents at Jefferies 2021 Virtual Healthcare Conference (Transcript)

Aurora Cannabis

Canopy Growth

GrowGeneration Corp

Some states are dealing with pot shortages in 2021 that are making it hard for marijuana companies to keep up with demand. The post Pot Shortages 2021: 18 Things for Marijuana Stock Investors to Know appeared first on InvestorPlace.

Pot Shortages 2021: 18 Things for Marijuana Stock Investors to Know

Despite the recent significant pullback in TLRY stock, the cannabis space is still frothy with little potential for another up leg in Tilray. The post Volatility In Tilray Will Likely Continue After Its Recent Merger appeared first on InvestorPlace.

Volatility In Tilray Will Likely Continue After Its Recent Merger

Will Tilray Stock Hit $25 in 2021?

HEXO Corp

Amplify Alternative Harvest ETF

OrganiGram Holdings Inc.

Wall Street closed the month on a positive note.

Why Pot Stocks Led Markets Higher Into the Holiday Weekend

Tilray Inc (NASDAQ:TLRY) broke bullish from a triangle on May 25 and on Wednesday its stock had bullish continuation. The move could be due to one or more of the following possibilities:

Why Is Tilray's Stock Surging And What's Next?

The company's path forward is different than its competitors'.

3 Things About Tilray That Successful Investors Know

Asensus Surgical

GT Biopharma Inc

GameStop (NYSE:GME) Is Surging Bringing Validity To Countless Penny Stocks Right Now The post Are Penny Stocks Worth It? 3 Cheap Stocks To Watch Before June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are Penny Stocks Worth It? 3 Cheap Stocks To Watch Before June 2021

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will webcast its fireside chats from the following investor conferences during June. On Tuesday, June 1, 2021, the Company will participate in the Jefferies Virtual Healthcare Conference. The fireside chat will begin at 8:30 AM ET. On Tuesday, June 8, 2021, the Company will participate in the Stifel Cross Sector Insight Conference. The fireside chat will begin at 4:00 PM

Tilray to Webcast Fireside Chats From Two Investor Conferences in June

Today, cannabis stocks are soaring as legalization legislation is expected to materialize this week, alongside other bullish catalysts. The post Cannabis Stocks: The Big News Sending TLRY, CGC, ACB, GRWG, SNDL Stocks Higher appeared first on InvestorPlace.

Cannabis Stocks: The Big News Sending TLRY, CGC, ACB, GRWG, SNDL Stocks Higher

An analyst upgrade and some positive political momentum are recent tailwinds for cannabis stocks.

Why Tilray, OrganiGram Holdings, and HEXO Stock Jumped Today

2 Canadian Marijuana Stocks To Watch Before Next Month The post Canadian Marijuana Stocks To Buy Right Now? 2 Traders Are Watching appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Buy Right Now? 2 Traders Are Watching

New data from Statistics Canada revealed that Canadian cannabis sales in March improved 65% year-over-year reaching CA$298.1 million ($246.7 million), reports New Cannabis Ventures. According to the outlet, this was the “slowest year-over-year growth” since recreational sales in the country began in late 2018.

Canadian Cannabis Sales In March Improve 65% YoY Reaching $246.7M

Aphria

When Tilray Inc's (NASDAQ:TLRY) formally merged with Aphria on May 3, it was a "sell the news" event. Tilray is trading down 14% from when the new Tilray was created and its stock has been stuck near a support and resistance level at $15.17 for the last 10 trading days.

How Is Tilray's Stock Chart Looking Since Aphria Merger?

When the federal Cannabis Act came into effect in October 2018 and Canada became the second country in the world, after Uruguay, to legalize adult-use cannabis, needless to say, the market exploded. Today the biggest names in the Canadian cannabis space include Aurora Cannabis (NYSE: ACB), Canopy Growth (NASDAQ: CGC), Hexo (NYSE: HEXO), Organigram Holdings (NASDAQ: OGI), and Tilray (NASDAQ: TLRY).

Analyst: Aurora, Canopy, Tilray And Other Canadian Cannabis Co. Performances By Province

Tilray, Inc. (TLRY) CEO Irwin Simon Presents at BMO Capital Markets Virtual 16th Annual Farm to Market Conference (Transcript)

Altria

TLRY stock could end up as a force in the cannabis sector, but investors' fears and hesitation and legalization remain unchanged. The post Tilray Stock Is Not Very Different Since Its Altria Merger appeared first on InvestorPlace.

Tilray Stock Is Not Very Different Since Its Altria Merger

The cannabis industry is faced with two main objectives: Finding the right product to competitively grow and then finding the right place to actually set up operations. Sale-leaseback options are a financing tool cannabis companies are increasingly using in their pursuit of non-traditional financing.

Sale/Lease Buyback Model - Why It's the Hottest Funding Method for Cannabis Properties Now and Why It May Soon Not Be So Hot…

Could These Marijuana Stocks Deliver Gains In May? The post Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now

Canadian Pot Stocks With Potential In May The post Are Canadian Cannabis Stocks Ready For A Rebound? 3 To Add To Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Cannabis Stocks Ready For A Rebound? 3 To Add To Your Watchlist Next Week

Li Auto Inc.

XPeng

Zoom Video

The Swiss National Bank initiated a position in Chinsese electric-vehicle maker Li Auto, and bought more shares of peer XPeng. The bank also bought more Zoom Video shares, and marijuana stock Tilray.

Swiss Central Bank Bought Li Auto, XPeng, Zoom, and This Marijuana Stock

The shares of Tilray Inc (NASDAQ: TLRY) have received a price target of $20 by Cowen. These are the details.

Tilray (TLRY) Stock: $20 Target By Cowen

Curaleaf Holdings, Inc.

Innovative Industrial Properties

Akerna Corp

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.

Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?

Tilray was named to Time.com's 2021 Time100 Most Influential Companies list days before merger. Is that a reason to buy TLRY stock?

News for Tilray Brands Stock (TLRY)